Immune system changes during COVID-19 recovery play key role in determining disease severity. (October 2020)
- Record Type:
- Journal Article
- Title:
- Immune system changes during COVID-19 recovery play key role in determining disease severity. (October 2020)
- Main Title:
- Immune system changes during COVID-19 recovery play key role in determining disease severity
- Authors:
- Fathi, Farshid
Sami, Ramin
Mozafarpoor, Samaneh
Hafezi, Hossein
Motedayyen, Hossein
Arefnezhad, Reza
Eskandari, Nahid - Abstract:
- Coronavirus disease 2019 (COVID-19), an acute respiratory infection, is largely associated with dysregulation and impairment of the immune system. This study investigated how the immune system changes were related to disease severity in COVID-19 patients. The frequencies of different immune cells and levels of pro- and anti-inflammatory cytokines in whole blood of participants were determined by flow cytometry and enzyme-linked immunosorbent assay, respectively. The values of other inflammatory agents were also studied. In the late recovery stage, unlike CD56 high CD16 +/− NK cells and monocytes, CD56 low CD16 + NK cell numbers were increased ( P < 0.0001–0.05). Th1, Th2, and Th17 cell percentages were significantly lower in patients than healthy control ( P < 0.0001–0.05), while their frequencies were increased following disease recovery ( P < 0.0001–0.05). The numbers of Tregs, activated CD4+ T cells, and exhausted CD8+ T cells were significantly decreased during a recovery ( P < 0.0001–0.05). No significant change was observed in exhausted CD4+ T cell number during a recovery ( P > 0.05). B cell showed an increased percentage in patients compared to healthy subjects ( P < 0.0001–0.05), whereas its number was reduced following recovery ( P < 0.0001–0.05). IL-1α, IL-1β, IL-6, TNF-α, and IL-10 levels were significantly decreased in the late recovery stage ( P < 0.0001–0.05). However, TGF-β1 level was not significantly changed during the recovery ( P > 0.05).Coronavirus disease 2019 (COVID-19), an acute respiratory infection, is largely associated with dysregulation and impairment of the immune system. This study investigated how the immune system changes were related to disease severity in COVID-19 patients. The frequencies of different immune cells and levels of pro- and anti-inflammatory cytokines in whole blood of participants were determined by flow cytometry and enzyme-linked immunosorbent assay, respectively. The values of other inflammatory agents were also studied. In the late recovery stage, unlike CD56 high CD16 +/− NK cells and monocytes, CD56 low CD16 + NK cell numbers were increased ( P < 0.0001–0.05). Th1, Th2, and Th17 cell percentages were significantly lower in patients than healthy control ( P < 0.0001–0.05), while their frequencies were increased following disease recovery ( P < 0.0001–0.05). The numbers of Tregs, activated CD4+ T cells, and exhausted CD8+ T cells were significantly decreased during a recovery ( P < 0.0001–0.05). No significant change was observed in exhausted CD4+ T cell number during a recovery ( P > 0.05). B cell showed an increased percentage in patients compared to healthy subjects ( P < 0.0001–0.05), whereas its number was reduced following recovery ( P < 0.0001–0.05). IL-1α, IL-1β, IL-6, TNF-α, and IL-10 levels were significantly decreased in the late recovery stage ( P < 0.0001–0.05). However, TGF-β1 level was not significantly changed during the recovery ( P > 0.05). Lymphocyte numbers in patients were significantly decreased ( P < 0.001), unlike ESR value ( P < 0.001). Lymphocyte number was negatively correlated to ESR value and Th2 number ( P < 0.05), while its association with monocyte was significantly positive at the first day of recovery ( P < 0.05). The immune system changes during the disease recovery to improve and regulate immune responses and thereby may associate with the reduction in disease severity. … (more)
- Is Part Of:
- International journal of immunopathology and pharmacology. Volume 34(2020)
- Journal:
- International journal of immunopathology and pharmacology
- Issue:
- Volume 34(2020)
- Issue Display:
- Volume 34, Issue 2020 (2020)
- Year:
- 2020
- Volume:
- 34
- Issue:
- 2020
- Issue Sort Value:
- 2020-0034-2020-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-10
- Subjects:
- COVID-19 -- disease recovery -- disease severity -- immune system -- immunodysregulation
Immunopathology -- Periodicals
Pharmacology -- Periodicals
Inflammation -- Periodicals
615.1 - Journal URLs:
- http://iji.sagepub.com/ ↗
http://www.uk.sagepub.com ↗ - DOI:
- 10.1177/2058738420966497 ↗
- Languages:
- English
- ISSNs:
- 0394-6320
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 14620.xml